Intriguingly, molecular subtyping of SCLC tumors demonstrates DLL3’s absence in ASCL1/NEUROD1 double-negative subtypes but high expression in ASCL1- or NEUROD1-dominant tumors (110, 111), underscoring its complex diagnostic utility. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.